Adaptimmune Therapeutics Plc - ADR - ADAP - stock price prediction, stock price target, analyst ratings from 3 analysts

Adaptimmune Therapeutics Plc - ADR has a share price target of US$ 1, revenue growth forecast of -77.3%, and profit growth estimate of -31.3% for FY25, based on top 3 analyst calls.